Immunotherapy: a new treatment paradigm in bladder cancer

por Davarpanah, Nicole N., Yuno, Akira, Trepel, Jane B., Apolo, Andrea B.
Publicado 2017

Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder

por Lee, Young H., Apolo, Andrea B., Agarwal, Piyush K., Bottaro, Donald P.
Publicado 2014

Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss

por Ramaswamy, Bharath, Roy, Soumen, Apolo, Andrea B., Shapiro, Benjamin, Depireux, Didier A.
Publicado 2017

Rapidly Progressing Urothelial Carcinoma Due to a Rare TP53 (p.Arg110Pro) Mutation: A Case Report and Review of the Literature

por Saoud, Ragheed, Sanford, Thomas H, Hewitt, Stephen M, Apolo, Andrea B, Agarwal, Piyush K
Publicado 2021

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

por Manitz, Juliane, D'Angelo, Sandra P, Apolo, Andrea B, Eggleton, S Peter, Bajars, Marcis, Bohnsack, Oliver, Gulley, James L
Publicado 2022

Cabozantinib for the treatment of solid tumors: a systematic review

por Maroto, Pablo, Porta, Camillo, Capdevila, Jaume, Apolo, Andrea B., Viteri, Santiago, Rodriguez-Antona, Cristina, Martin, Lidia, Castellano, Daniel
Publicado 2022

Cabozantinib combination therapy for the treatment of solid tumors: a systematic review

por Castellano, Daniel, Apolo, Andrea B., Porta, Camillo, Capdevila, Jaume, Viteri, Santiago, Rodriguez-Antona, Cristina, Martin, Lidia, Maroto, Pablo
Publicado 2022

Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report

por Monge, Cecilia, Maeng, Hoyoung, Brofferio, Alessandra, Apolo, Andrea B., Sathya, Bharath, Arai, Andrew E., Gulley, James L., Bilusic, Marijo
Publicado 2018

Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature

por Cordes, Lisa M., Davarpanah, Nicole N., Reoma, Lauren B., Gasmi, Billel, Quezado, Martha, Khan, Omar I., Nath, Avindra, Apolo, Andrea B.
Publicado 2019

Efficacy and immune-related adverse event associations in avelumab-treated patients

por Kelly, Karen, Manitz, Juliane, Patel, Manish R, D’Angelo, Sandra P, Apolo, Andrea B, Rajan, Arun, Kasturi, Vijay, Speit, Isabell, Bajars, Marcis, Warth, John, Gulley, James L
Publicado 2020

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

por Abida, Wassim, Milowsky, Matthew I., Ostrovnaya, Irina, Gerst, Scott R., Rosenberg, Jonathan E., Voss, Martin H., Apolo, Andrea B., Regazzi, Ashley M., McCoy, Asia S., Boyd, Mariel E., Bajorin, Dean F.
Publicado 2016

Use of Magnetic Resonance Imaging to Identify Immune Checkpoint Inhibitor–Induced Inflammatory Arthritis

por Subedi, Ananta, Williams, Sandra G., Yao, Lawrence, Maharjan, Suresh, Strauss, Julius, Sharon, Elad, Thomas, Anish, Apolo, Andrea B., Gourh, Pravitt, Hasni, Sarfaraz A., Gulley, James L., Kaplan, Mariana J., Katz, James D., Gupta, Sarthak
Publicado 2020

Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder

por Lee, Young H., Lee, Molly M., De Silva, Dinuka M., Roy, Arpita, Wright, Cara E., Wong, Tiffany K., Costello, Rene, Olaku, Oluwole, Grubb, Robert L., Agarwal, Piyush K., Apolo, Andrea B., Bottaro, Donald P.
Publicado 2021

Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

por Apolo, Andrea B., Infante, Jeffrey R., Balmanoukian, Ani, Patel, Manish R., Wang, Ding, Kelly, Karen, Mega, Anthony E., Britten, Carolyn D., Ravaud, Alain, Mita, Alain C., Safran, Howard, Stinchcombe, Thomas E., Srdanov, Marko, Gelb, Arnold B., Schlichting, Michael, Chin, Kevin, Gulley, James L.
Publicado 2017

(18)F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab

por Lim, Ilhan, Lindenberg, Maria Liza, Mena, Esther, Verdini, Nicholas, Shih, Joanna H., Mayfield, Christian, Thompson, Ryan, Lin, Jeffrey, Vega, Andy, Mallek, Marissa, Cadena, Jacqueline, Diaz, Carlos, Mortazavi, Amir, Knopp, Michael, Wright, Chadwick, Stein, Mark, Pal, Sumanta, Choyke, Peter L., Apolo, Andrea B.
Publicado 2019

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

por Apolo, Andrea B, Ellerton, John A, Infante, Jeffrey R, Agrawal, Manish, Gordon, Michael S, Aljumaily, Raid, Gourdin, Theodore, Dirix, Luc, Lee, Keun-Wook, Taylor, Matthew H, Schöffski, Patrick, Wang, Ding, Ravaud, Alain, Manitz, Juliane, Pennock, Gregory, Ruisi, Mary, Gulley, James L, Patel, Manish R
Publicado 2020

Genetic Variant as a Selection Marker for Anti–Prostate Stem Cell Antigen Immunotherapy of Bladder Cancer

por Kohaar, Indu, Porter-Gill, Patricia, Lenz, Petra, Fu, Yi-Ping, Mumy, Adam, Tang, Wei, Apolo, Andrea B., Rothman, Nathaniel, Baris, Dalsu, Schned, Alan R., Ylaya, Kris, Schwenn, Molly, Johnson, Alison, Jones, Michael, Kida, Masatoshi, Silverman, Debra T., Hewitt, Stephen M., Moore, Lee E., Prokunina-Olsson, Ludmila
Publicado 2013

Predicting cancer immunotherapy response from gut microbiomes using machine learning models

por Liang, Hai, Jo, Jay-Hyun, Zhang, Zhiwei, MacGibeny, Margaret A., Han, Jungmin, Proctor, Diana M., Taylor, Monica E., Che, You, Juneau, Paul, Apolo, Andrea B., McCulloch, John A., Davar, Diwakar, Zarour, Hassane M., Dzutsev, Amiran K., Brownell, Isaac, Trinchieri, Giorgio, Gulley, James L., Kong, Heidi H.
Publicado 2022

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome

por Dinstag, Gal, Shulman, Eldad D., Elis, Efrat, Ben-Zvi, Doreen S., Tirosh, Omer, Maimon, Eden, Meilijson, Isaac, Elalouf, Emmanuel, Temkin, Boris, Vitkovsky, Philipp, Schiff, Eyal, Hoang, Danh-Tai, Sinha, Sanju, Nair, Nishanth Ulhas, Lee, Joo Sang, Schäffer, Alejandro A., Ronai, Ze’ev, Juric, Dejan, Apolo, Andrea B., Dahut, William L., Lipkowitz, Stanley, Berger, Raanan, Kurzrock, Razelle, Papanicolau-Sengos, Antonios, Karzai, Fatima, Gilbert, Mark R., Aldape, Kenneth, Rajagopal, Padma S., Beker, Tuvik, Ruppin, Eytan, Aharonov, Ranit
Publicado 2023

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

por Girardi, Daniel M., Niglio, Scot A., Mortazavi, Amir, Nadal, Rosa, Lara, Primo, Pal, Sumanta K., Saraiya, Biren, Cordes, Lisa, Ley, Lisa, Ortiz, Olena Sierra, Cadena, Jacqueline, Diaz, Carlos, Bagheri, Hadi, Redd, Bernadette, Steinberg, Seth M., Costello, Rene, Chan, Keith S., Lee, Min-Jung, Lee, Sunmin, Yu, Yunkai, Gurram, Sandeep, Chalfin, Heather J., Valera, Vladimir, Figg, William D., Merino, Maria, Toubaji, Antoun, Streicher, Howard, Wright, John J., Sharon, Elad, Parnes, Howard L., Ning, Yang-Min, Bottaro, Donald P., Cao, Liang, Trepel, Jane B., Apolo, Andrea B.
Publicado 2022